Serum tumour markers, such as carcinoembryonic antigen (CEA) and carbohydrate antigen 19 − 9 (CA19-9), are widely used in the early diagnosis and prognosis of colorectal cancer, but the sensitivity and specificity for early CRC are unsatisfactory [17]. This evidence concerns the gene CEACAM5 and colorectal carcinoma.